PharmaForceIQ Launches Optichannel 360 for Pharma Commercial Teams

Aug 26, 2026
PharmaForceIQ has launched Optichannel 360, an AI native commercial execution platform for pharmaceutical teams that connects field and digital marketing workflows.

PharmaForceIQ announced in a press release the launch of Optichannel 360, an AI native commercial execution platform for pharmaceutical commercial teams. The platform connects field sales and digital marketing with workflows for measurement, decisioning, approval, and execution.

The first packaged capability is a measurement answer to action workflow. It lets teams ask performance questions, review sourced answers at the NPI level, and route approved next steps back into execution workflows.

PharmaForceIQ said Optichannel 360 uses a connected decision model across field and digital channels, based on more than 200 million industry contextual data points. The company is rolling out the platform first to existing clients.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Sales & Marketing AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Brief AI Brief (X)
Free newsletter

Sales & Marketing AI Weekly

News about AI tools and innovations for Sales and Marketing professionals.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.